Specifically, in the U.S., the CDC recommends permissive use of serogroup B meningococcal vaccine for adolescents and young adults age 16-23, with a preferred age of 16 to 18. The CDC recommended the type B vaccine in 2015, and therefore many have not yet received the vaccine. According to the CDC, Meningococcal disease vaccines are safe and effective. Common side effects of the vaccines are mild, but can include a sore arm, headache, or fatigue. More details on meningococcal disease vaccine safety can be found here on the CDC website here.
Parents and their children should discuss both the conjugate and MenB vaccines with their doctors. For detailed recommendations about vaccination in adolescents and young adults, visit the CDC website.